Sunscreen maker Solesence posts Q3 net loss as revenue drops

Reuters
Nov 11, 2025
Sunscreen maker Solesence posts Q3 net loss as revenue drops

Overview

  • Solesence Q3 revenue fell to $14.5 mln from $16.9 mln in 2024

  • Company reports Q3 net loss of $1.1 mln, down from net income of $3.0 mln

  • Gross margin declined to 23% from 36% in Q3 2024

Outlook

  • Company did not provide specific financial guidance for future quarters or years

Result Drivers

  • OPERATIONAL EFFICIENCIES - Solesence consolidated manufacturing facilities and improved automation to enhance operational efficiency

  • STRATEGIC TRANSFORMATION - Solesence implemented strategic initiatives to drive improvements in innovation, product quality, and operational efficiency

  • LEADERSHIP CHANGES - Solesence appointed new executives to drive strategic planning and operational improvements

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

$14.50 mln

Q3 EPS

-$0.02

Q3 Net Income

-$1.12 mln

Q3 Gross Profit

$3.37 mln

Q3 Income From Operations

-$781,000

Press Release: ID:nGNX9L1B8V

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10